J
Journey Medical Corporation (DERM)
NCM – Real vaqt narxi. Valyuta: USD
5.01
+0.01 (0.20%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
5.01
+0.01 (0.20%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Journey Medical Corporation - bu tijorat bosqichidagi farmatsevtika kompaniyasi bo'lib, Qo'shma Shtatlarda dermatologik kasalliklarni davolash uchun farmatsevtika mahsulotlarini ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniyaning sotiladigan mahsulotlari orasida birlamchi aksillyar gipergidrozni davolash uchun dori bilan singdirilgan salfetka bo'lgan Qbrexza; og'ir, davolashga chidamli nodulyar akne davolash uchun og'iz orqali yuboriladigan izotretinoin preparati Accutane; va o'rta va og'ir darajadagi nodulyar bo'lmagan akne vulgarisning yallig'lanishli lezyonlarini davolash uchun minotsiklinsimon topik preparat Amzeeq kiradi. Shuningdek, u rosatsiyaning yallig'lanishli lezyonlarini davolash uchun topik minotsiklinli Zilxi; rosatsiyaning yallig'lanishli lezyonlarini davolash uchun Emrosi; qo'ziqorinli teri infektsiyalarini davolash uchun Exelderm krem va eritmasi; va og'ir akne uchun qo'shimcha terapiya sifatida og'iz orqali yuboriladigan doksitsiklin preparati Targadox, shuningdek, sirt yaralari; mayda kesiklar yoki tirnalishlar; dermal yaralar; donor joylari; quyosh yonishi bilan bir qatorda birinchi va ikkinchi darajali kuyishlar; va radiatsiya dermatitini davolash uchun nam shifo muhitini ta'minlash uchun mo'ljallangan suv asosidagi emulsiya Luxamendni taqdim etadi. Kompaniya ilgari Coronado Dermatology, Inc. nomi bilan tanilgan. Journey Medical Corporation 2014 yilda tashkil etilgan va shtab-kvartirasi Skotsdeyl, Arizona shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Lindsay Allan Rosenwald M.D. | Executive Chairman |
| Jaclyn Jaffe | Senior Director of Corporate Operations |
| Mr. Claude Maraoui | Founder, President, CEO & Director |
| Mr. Joseph M. Benesch | CFO & Corporate Controller |
| Mr. Louis Donati | Director of Market Access |
| Mr. Ramsey Alloush | COO, General Counsel & Company Secretary |
| Mr. Robert Nevin | Chief Commercial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | DEF 14A | tm261508-3_def14a.htm |
| 2026-04-21 | 8-K | tm2612310d1_8k.htm |
| 2026-03-26 | 10-K | derm-20251231x10k.htm |
| 2026-03-25 | 8-K | tm269707d1_8k.htm |
| 2026-01-15 | S-3 | tm2534369d2_s3.htm |
| 2025-12-30 | DRS | filename1.htm |
| 2025-11-12 | 10-Q | derm-20250930x10q.htm |
| 2025-09-26 | 8-K | tm2527082d1_8k.htm |
| 2025-08-28 | 8-K | tm2524202d2_8kseq1.htm |
| 2025-08-12 | 8-K | tm2523268d1_8k.htm |